Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2008 (Vol. 28, No. 5)


  • Very interesting design and potential
  • Only an alpha release
Freebase is an open, shared database of the world’s knowledge, or so it says on their opening page. Given that the system contains over 3.2 million topics, their claim may not be too inaccurate. The real test of a site for me is how well it deals with scientific information and it was with that in mind that I surveyed Freebase. Prominent on the opening page is a Science/Technology section with a pop-up menu that leads directly to Biology. Under that subsection, I was a bit frustrated at the lack of hierarchy to get me to material I was interested in. The online tutorial showed options not yet apparently enabled in biology for searching for information, so I wasn’t able to test the depth of Freebase information for biology. I was, however, very impressed by the design I saw in the tutorial, so it will be interesting to see how this one plays out. I note that the pages are currently only in alpha release, so there is a long way to go. Still, Freebase looks to be a very promising marriage of a Wiki and a search engine. Come back later for this one.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »